Literature DB >> 743805

Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.

C H Kirkpatrick, L E Greenberg, S W Chapman, G Goldstein, V M Lewis, J J Twomey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 743805      PMCID： PMC1537547     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  24 in total

1.  Transfer factor II: results of therapy.

Authors:  L E Spitler; A S Levin; H H Fudenberg
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue.

Authors:  M Ballow; L R Hyman
Journal:  Clin Immunol Immunopathol       Date:  1977-11

3.  Immunodeficiencies in chronic muco-cutaneous candidosis.

Authors:  T Lehner; J M Wilton; L Ivanyi
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

4.  Thymic transplantation in a case of chronic mucocutaneous candidiasis.

Authors:  R L Levy; M L Bach; S Huang; F H Bach; R Hong; A J Ammann; M Bortin; H E Kay
Journal:  Lancet       Date:  1971-10-23       Impact factor: 79.321

5.  Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.

Authors:  J J Twomey; G Goldstein; V M Lewis; P M Bealmear; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

6.  The two-step leukocyte migration inhibition factor (LIF) assay. Its use in evaluation of cellular immune function in patients with immunodeficiency diseases.

Authors:  S W Chapman; C H Kirkpatrick
Journal:  Cell Immunol       Date:  1978-04       Impact factor: 4.868

7.  Human cells required for macrophage migration inhibitory factor (MIF) production.

Authors:  J J Twomey; S Lazar; R E Rocklin
Journal:  Clin Immunol Immunopathol       Date:  1977-11

8.  Circulating thymic-hormone activity in congenital immunodeficiency.

Authors:  V Lewis; J J Twomey; G Goldstein; R O'Reilly; E Smithwick; R Pahwa; S Pahwa; R A Good; H Schulte-Wisserman; S Horowitz; R Hong; J Jones; O Sieber; C Kirkpatrick; S Polmar; P Bealmear
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307
View more
  5 in total

Review 1.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

Review 2.  Chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

3.  Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

Authors:  W Savino; G Manganella; J M Verley; A Wolff; S Berrih; P Levasseur; J P Binet; M Dardenne; J F Bach
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 4.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985

Review 5.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.